| 0.7035 -0.057 (-7.53%) | 10-16 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 1.23 | 1-year : | 1.51 |
| Resists | First : | 1.05 | Second : | 1.29 |
| Pivot price | 0.83 |
|||
| Supports | First : | 0.67 | Second : | 0.55 |
| MAs | MA(5) : | 0.74 |
MA(20) : | 0.83 |
| MA(100) : | 1.01 |
MA(250) : | 1.75 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 7.5 |
D(3) : | 8.1 |
| RSI | RSI(14): 39.6 |
|||
| 52-week | High : | 4.69 | Low : | 0.67 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ FLNA ] has closed above bottom band by 8.4%. Bollinger Bands are 3.2% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 0.76 - 0.77 | 0.77 - 0.77 |
| Low: | 0.69 - 0.7 | 0.7 - 0.7 |
| Close: | 0.7 - 0.7 | 0.7 - 0.71 |
Filana Therapeutics, Inc. is a company dedicated to pioneering new pharmaceutical products and diagnostic technologies. A key area of its research is focused on creating potential treatments for Alzheimer's disease, including the investigational compounds PTI-125 and PTI-125Dx. Established by Remi Barbier in May 1998, the firm maintains its principal office in Austin, Texas.
Fri, 09 Oct 2026
Filana Therapeutics to Participate in the 2026 Maxim Growth Summit - GlobeNewswire
Wed, 23 Sep 2026
Filana Therapeutics Inc. (FLNA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Tue, 22 Sep 2026
Why Is Filana Therapeutics Stock Trading Higher Today? - Filana Therapeutics (NASDAQ:FLNA) - Benzinga
Tue, 22 Sep 2026
A rare epilepsy trial can now move ahead after FDA lifts its hold on simufilam. - Stock Titan
Sun, 20 Sep 2026
Filana Therapeutics, Inc.(NasdaqCM: FLNA) dropped from S&P Global BMI Index - marketscreener.com
Wed, 12 Aug 2026
Did Filana Therapeutics, Inc. Insiders Breach their Fiduciary Duties to Shareholders? - Morningstar
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Biotechnology
|
|
| Shares Out | 48 (M) |
| Shares Float | 47 (M) |
| Held by Insiders | 2 (%) |
| Held by Institutions | 26.8 (%) |
| Shares Short | 5,890 (K) |
| Shares Short P.Month | 6,290 (K) |
| EPS | -0.88 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 1.32 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | -7.2 % |
| Return on Equity (ttm) | -55.8 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | -0.33 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | -0.27 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -29 (M) |
| Levered Free Cash Flow | 4 (M) |
| PE Ratio | -0.81 |
| PEG Ratio | 1.6 |
| Price to Book value | 0.53 |
| Price to Sales | 0 |
| Price to Cash Flow | -1.19 |
| Dividend | 5.25 |
| Forward Dividend | 0 |
| Dividend Yield | 746.2% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|